Affordability, availability and tolerability of anti-seizure medications are better predictors of adherence than beliefs: Changing paradigms from a low resource setting. (December 2020)

• Record Type: Journal Article
• Authors: Sunny, Anita Ann; Iyer, Rajesh Shankar; Kumaran, Soumya Gopalan; Bunshaw, Nadiya Grace; Shanmugham, Karthikeyan; Govindaraj, Uma
• Is Part Of: Seizure. Volume 83(2020)
• Page Start: 208
• Page End: 215
• Publication Date: 2020-12
• Subjects: Necessity-concern differential -- ASM costs -- Newer ASMs -- ASM availability -- ASM side effects; Epilepsy -- Periodicals; Epilepsy -- Periodicals; Seizures -- Periodicals; Épilepsie -- Périodiques; Electronic journals; Electronic journals; 616.853
• DOI: 10.1016/j.seizure.2020.11.003
• Languages: English
• ISSNs: 1059-1311

Abstract

Graphical abstract: Highlights: Prevalence and predictors of anti-seizure medication (ASM) non-adherence were evaluated among 304 adults with epilepsy (AWE). The non-adherence rate was high at 55 % despite having positive beliefs in this literate, low income group of AWE. The clinico-demographic factors including ASM costs, availability and tolerability were better predictors than beliefs High literacy acted as a protective factor against non-adherence by improving the perception of need for ASMs. Making good quality generic ASMs available would facilitate adherence more than interventions to improve beliefs in our AWE Abstract: Objectives: Anti-seizure medication (ASM) non-adherence contributes to treatment gap and increases mortality and morbidity associated with epilepsy. Beliefs about medications are considered better predictors of ASM non-adherence than clinico-demographic factors. We aimed to look into ASM non-adherence rates among adults with epilepsy (AWE), identify the contributing barriers and determine whether medication beliefs were more powerful predictors than clinico-demographic factors. Methods: This was a cross-sectional study of AWE receiving ASMs. Participants (n = 304) were assessed by validated questionnaires, for non-adherence (8-item Morisky Medication Adherence Scale) and perceptions of ASMs (Beliefs about Medicines Questionnaire) along with clinico-demographic details. Results: Our group with high literacy and low-income had a high non-adherence rate (55 %) despite having positive beliefs (Mean necessity-concern differential [NCD] = 2.86). Among the beliefs, ASM non-adherence was significantly associated with ASM-concern (t = 4.23, p < 0.001) and NCD (t = −4.11, p < 0.001). Stepwise multiple linear regression analysis showed that non-adherence was significantly associated with per-capita income (β −0.215, p < 0.001), ASM side effects (β 0.177, p = 0.001), high seizure frequency (β 0.167, p = 0.002), ASM availability (β −0.151, p = 0.004), ASM costs (β −0.134, p = 0.013 and NCD (β −0.184, p = 0.001). NCD accounted for 2.9 % of the variance in non-adherence whereas the other clinico-demographic variables together accounted for 14.6 %. Conclusion: We describe a paradigm shift in AWE with high non-adherence to ASMs, wherein clinico-demographic variables emerge as better predictors of non-adherence than beliefs. High literacy facilitates the perception of need for ASMs whereas costs and side effects hamper adherence.